Alistair Leanord

758 total citations
28 papers, 518 citations indexed

About

Alistair Leanord is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Alistair Leanord has authored 28 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Epidemiology and 5 papers in Clinical Biochemistry. Recurrent topics in Alistair Leanord's work include Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotic Resistance in Bacteria (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Alistair Leanord is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotic Resistance in Bacteria (5 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Alistair Leanord collaborates with scholars based in United Kingdom, Greece and United States. Alistair Leanord's co-authors include Matthew T. G. Holden, David M. Livermore, Stephen Fox, Thomas J. Evans, Neil Woodford, Michael T. Ford, Jane A. Steer, Jiancheng Zhang, Jeremy McMahon and N. Hammersley and has published in prestigious journals such as Water Research, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Alistair Leanord

26 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alistair Leanord United Kingdom 14 199 170 111 105 91 28 518
Toshiki Kajihara Japan 13 127 0.6× 139 0.8× 127 1.1× 48 0.5× 89 1.0× 34 454
Robert Tibbetts United States 13 219 1.1× 185 1.1× 189 1.7× 91 0.9× 212 2.3× 42 627
Çiğdem Kuzucu Türkiye 11 154 0.8× 132 0.8× 105 0.9× 69 0.7× 94 1.0× 42 431
Ping-Cherng Chiang Taiwan 13 164 0.8× 146 0.9× 133 1.2× 51 0.5× 58 0.6× 22 460
Aki Hirabayashi Japan 15 238 1.2× 101 0.6× 126 1.1× 67 0.6× 85 0.9× 39 543
Javier Cobo Spain 11 385 1.9× 157 0.9× 177 1.6× 140 1.3× 57 0.6× 26 591
Kwok-Woon Yu Taiwan 13 272 1.4× 158 0.9× 240 2.2× 196 1.9× 72 0.8× 17 638
S. Nys Netherlands 12 172 0.9× 111 0.7× 281 2.5× 87 0.8× 129 1.4× 21 521
Véronique Vernet-Garnier France 13 206 1.0× 93 0.5× 115 1.0× 78 0.7× 48 0.5× 30 445
Zohreh Aminzadeh Iran 9 274 1.4× 76 0.4× 112 1.0× 120 1.1× 40 0.4× 42 474

Countries citing papers authored by Alistair Leanord

Since Specialization
Citations

This map shows the geographic impact of Alistair Leanord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alistair Leanord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alistair Leanord more than expected).

Fields of papers citing papers by Alistair Leanord

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alistair Leanord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alistair Leanord. The network helps show where Alistair Leanord may publish in the future.

Co-authorship network of co-authors of Alistair Leanord

This figure shows the co-authorship network connecting the top 25 collaborators of Alistair Leanord. A scholar is included among the top collaborators of Alistair Leanord based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alistair Leanord. Alistair Leanord is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McHugh, M., Samuel Horsfield, Kerry A. Pettigrew, et al.. (2025). Integrated population clustering and genomic epidemiology with PopPIPE. Microbial Genomics. 11(4).
2.
3.
Williams, David J., Giuseppina Mariano, Grant Buchanan, et al.. (2025). Competitive behaviors in Serratia marcescens are coordinately regulated by a lifestyle switch frequently inactivated in the clinical environment. Cell Host & Microbe. 33(2). 252–266.e5. 1 indexed citations
4.
Bou-Antoun, Sabine, Alistair Leanord, R.A. Seaton, et al.. (2024). Adaptation of the WHO AWaRe (Access, Watch, Reserve) antibiotic classification to support national antimicrobial stewardship priorities in the UK: findings from a modified Delphi approach to achieve expert consensus. JAC-Antimicrobial Resistance. 7(1). dlae218–dlae218. 3 indexed citations
5.
McCowan, Colin, Alex McConnachie, William Malcolm, et al.. (2022). E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community. BMC Infectious Diseases. 22(1). 805–805. 14 indexed citations
6.
Fox, Stephen, et al.. (2021). Genomic Analysis of Global Staphylococcus argenteus Strains Reveals Distinct Lineages With Differing Virulence and Antibiotic Resistance Gene Content. Frontiers in Microbiology. 12. 795173–795173. 21 indexed citations
7.
Robertson, Chris, Jiafeng Pan, Kimberley Kavanagh, et al.. (2020). Cost burden of Clostridioides difficile infection to the health service: A retrospective cohort study in Scotland. Journal of Hospital Infection. 106(3). 554–561. 8 indexed citations
8.
Fox, Stephen, Matthew T. G. Holden, James P. R. Connolly, et al.. (2020). A highly conserved complete accessory Escherichia coli type III secretion system 2 is widespread in bloodstream isolates of the ST69 lineage. Scientific Reports. 10(1). 4135–4135. 13 indexed citations
9.
10.
Photos-Jones, Effie, et al.. (2017). Archaeological medicinal earths as antibacterial agents: the case of the Basel Lemnian sphragides. Geological Society London Special Publications. 452(1). 141–153. 9 indexed citations
11.
Wilson, A.P.R., David M. Livermore, Jonathan A. Otter, et al.. (2015). Prevention and control of multi-drug-resistant Gram-negative bacteria: recommendations from a Joint Working Party. Journal of Hospital Infection. 92. S1–S44. 94 indexed citations
12.
Wright, Teresa L., Anand Kumar, Sujeev Mathur, et al.. (2011). Epidemiology and management of candidaemia - a retrospective, multicentre study in five hospitals in the UK. Mycoses. 54(6). e795–e800. 30 indexed citations
13.
Reilly, J., Kimberley Kavanagh, Alistair Leanord, et al.. (2011). A Retrospective Cohort Study into Acquisition of MRSA and Associated Risk Factors after Implementation of Universal Screening in Scottish Hospitals. Infection Control and Hospital Epidemiology. 32(9). 889–896. 11 indexed citations
14.
McMahon, Jeremy, et al.. (2009). Microbiology of odontogenic infections in deep neck spaces: A retrospective study. British Journal of Oral and Maxillofacial Surgery. 48(1). 37–39. 47 indexed citations
15.
Cheng, Kenneth K.Y., et al.. (2009). Quantitative Analysis of Bacteria in Forefoot Surgery: A Comparison of Skin Preparation Techniques. Foot & Ankle International. 30(10). 992–997. 27 indexed citations
16.
Leanord, Alistair, et al.. (2003). First rotavirus, now astrovirus: the evolving benefits of RT-PCR.. PubMed. 6(1). 66–7. 6 indexed citations
17.
Mackay, William G., Alistair Leanord, & Craig Williams. (2002). Water, water everywhere nor any a sterile drop to rinse your endoscope. Journal of Hospital Infection. 51(4). 256–261. 17 indexed citations
18.
Leanord, Alistair & Craig Williams. (2002). Haemophilus influenzae in acute exacerbations of chronic obstructive pulmonary disease. International Journal of Antimicrobial Agents. 19(5). 371–375. 5 indexed citations
19.
Leanord, Alistair. (1996). Is MRSA a risk in the community?. PubMed. 240(1564). 444–8. 1 indexed citations
20.
Leanord, Alistair, et al.. (1992). Citrobacter diversus brain abscess: case reports and molecular epidemiology. Journal of Medical Microbiology. 36(4). 273–278. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiki Kajihara Breakdown of academic impact, for papers by Robert Tibbetts Breakdown of academic impact, for papers by Çiğdem Kuzucu Breakdown of academic impact, for papers by Ping-Cherng Chiang Breakdown of academic impact, for papers by Aki Hirabayashi Breakdown of academic impact, for papers by Javier Cobo Breakdown of academic impact, for papers by Kwok-Woon Yu Breakdown of academic impact, for papers by S. Nys Breakdown of academic impact, for papers by Véronique Vernet-Garnier Breakdown of academic impact, for papers by Zohreh Aminzadeh
Rankless by CCL
2026